Clinical trial Recruiting at 1 site Interventional Ages 21 and up

Oral nicotine pouches versus patches and lozenges to reduce cigarette use in rural Appalachia

Official title: Testing Oral Nicotine Pouches to Reduce Smoking-Related Cancer in Rural Appalachia

Run by Ohio State University Comprehensive Cancer Center · NCT06763536 · Data updated 2026-11-12

This compares oral nicotine pouches with nicotine patches and lozenges to see if they help adults in rural Appalachia who smoke cut down or quit cigarettes.

More Cigarette Smoking-Related Carcinoma trials

Quick facts

Study typeInterventional
Ages21 Years and up
SexAll
Enrollment1000 (estimated)
SponsorOhio State University Comprehensive Cancer Center
Academic / other
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedJune 13, 2025
Main results expectedDecember 31, 2028
Study endsDecember 31, 2028
Registry record updatedJune 30, 2026
Trial IDNCT06763536 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are English-speaking adults 21 or older who live in a rural Appalachian county, smoke ≥5 cigarettes per day, and are willing to try ONPs or NRT and use a smartphone for study tasks.

Probably not a fit

People currently using cessation medications or NRT, who used ONPs or NRT within the past three months, who use other tobacco products frequently, or who have unstable medical or psychiatric conditions are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults who smoke at least five cigarettes per day and live in rural Appalachian counties are randomized to receive either oral nicotine pouches (ONPs) or standard nicotine replacement therapy (patches and lozenges). Participants sample different flavors and strengths for two weeks to choose a preferred product, then use that product in place of cigarettes for a 12-week intervention with regular surveys and exhaled carbon monoxide (CO) checks. The study measures short-term switching and abstinence, product appeal, cravings, withdrawal relief, perceived dependence, and sustained tobacco behaviors through a 14-week post-intervention follow-up. Smartphones and handheld CO devices are used for data collection when needed.

Why it matters

Potential benefit: If successful, this approach could offer a more acceptable option to help Appalachian smokers reduce cigarette use and lower lung and oral cancer risk.

How similar studies have gone: Nicotine patches and lozenges have well-established efficacy for quitting, while oral nicotine pouches are a newer, less-studied alternative with limited clinical trial evidence to date.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Read and speak English
* 21 years or older
* Smoke ≥ 5 cigarettes per day for the past year
* Willing to use Oral Nicotine Pouches (ONP) or Nicotine Replacement Therapy (NRT)
* Live in a rural Appalachian County
* Have a smartphone and/or willing to use a smartphone for study purposes (smartphones may be provided to participants for study purposes only)
* Willing to blow air into a handheld study device
* If capable of becoming pregnant, verbal confirmation of not being pregnant based on urine pregnancy test results

Exclusion Criteria:

* Report currently using smoking cessation medications, NRT, or actively seeking treatment for smoking cessation
* Use of ONPs in past 3 months
* Use of Nicotine Replacement Therapies in past 3 months
* Use of other tobacco products \> 10 days/month
* Unstable or significant medical condition
* Unstable or significant psychiatric conditions (past and stable conditions will be allowed)
* History of cardiac event or distress within the past 3 months
* Live in same household as another study participant.
* Currently pregnant, planning to become pregnant within 6 months, or breastfeeding

Where it's running

  • Ohio State University Comprehensive Cancer Center
    Columbus, Ohio, United States
    Recruiting

Study contacts

  • Principal investigator: Brittney L Keller-Hamilton, PhD, MPH — Ohio State University Comprehensive Cancer Center
  • Study coordinator: The Ohio State University Comprehensive Cancer Center
  • Email: OSUCCCClinicaltrials@osumc.edu
  • Phone: 800-293-5066

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.